The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

(2012) Cornelius Katona et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

(2012) Mark J. Millan et al.   NATURE REVIEWS DRUG DISCOVERY

Cognitive deficits in the remitted state of unipolar depressive disorder.

(2012) Bo Jacob Hasselbalch et al.   NEUROPSYCHOLOGY

Effect of low-dose acute tryptophan depletion on the specificity of autobiographical memory in healthy subjects with a family history of depression

(2012) Hamid A. Alhaj et al.   PSYCHOPHARMACOLOGY

Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men

(2011) Marieke Liem-Moolenaar et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

5-HT6 receptor and cognition

(2011) Xabier Codony et al.   CURRENT OPINION IN PHARMACOLOGY

Neurocognitive impairment in adolescent major depressive disorder: State vs. trait illness markers

(2011) Fadi T. Maalouf et al.   JOURNAL OF AFFECTIVE DISORDERS

A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder

(2011) Rico S.C. Lee et al.   JOURNAL OF AFFECTIVE DISORDERS

Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication

(2011) Shawn M. McClintock et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

(2011) Benny Bang-Andersen et al.   JOURNAL OF MEDICINAL CHEMISTRY

Neuropsychological Clustering Highlights Cognitive Differences In Young People Presenting With Depressive Symptoms

(2011) Daniel F. Hermens et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits

(2011) M. Victoria Puig et al.   MOLECULAR NEUROBIOLOGY

Pharmacological Blockade of Serotonin 5-HT7 Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission

(2011) Pascal Bonaventure et al.   PLoS One

More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia

(2011) Jan-Henry Stenberg et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Abnormal prefrontal activity subserving attentional control of emotion in remitted depressed patients during a working memory task with emotional distracters

(2011) R. Kerestes et al.   PSYCHOLOGICAL MEDICINE

Therapeutic Potential of 5-HT2CReceptor Ligands

(2011) Nanna H. Jensen et al.   TheScientificWorldJOURNAL

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia

(2010) Gabriel Selva-Vera et al.   BMC Psychiatry

F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists

(2010) Ronan Depoortère et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers

(2010) Barbara Drueke et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers

(2010) Masahiro Takahashi et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Cognitive function and risk for depression in old age: a meta-analysis of published literature

(2010) Chang-Quan Huang et al.   INTERNATIONAL PSYCHOGERIATRICS

Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review

(2010) Bo Jacob Hasselbalch et al.   JOURNAL OF AFFECTIVE DISORDERS

5-HT3 receptors: Role in disease and target of drugs

(2010) Jutta Walstab et al.   PHARMACOLOGY & THERAPEUTICS

Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: A randomized controlled trial

(2010) Sung Joon Cho et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Drug development for Alzheimer's disease: Where are we now and where are we headed?

(2009) Marwan N. Sabbagh   American Journal Geriatric Pharmacotherapy

A Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Young People at Increased Familial Risk of Depression

(2009) Zola N. Mannie et al.   BIOLOGICAL PSYCHIATRY

Acute citalopram administration may disrupt contextual information processing in healthy males

(2009) S. Almeida et al.   EUROPEAN PSYCHIATRY

Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study

(2009) Jan-Henry Stenberg et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A meta-analysis of depression severity and cognitive function

(2009) Lisa M. McDermott et al.   JOURNAL OF AFFECTIVE DISORDERS

Major Depressive Disorder in recovery and neuropsychological functioning: Effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery

(2009) Ixchel Herrera-Guzmán et al.   JOURNAL OF AFFECTIVE DISORDERS

Design, Synthesis, and Biological Evaluation of New 5-HT4Receptor Agonists: Application as Amyloid Cascade Modulators and Potential Therapeutic Utility in Alzheimer’s Disease

(2009) Olivier Russo et al.   JOURNAL OF MEDICINAL CHEMISTRY

Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

(2009) Ixchel Herrera-Guzmán et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Effects of acute tryptophan depletion on memory, attention and executive functions: A systematic review

(2009) Daniel Mendelsohn et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity

(2009) Anneke D. M. Haddad et al.   PSYCHOPHARMACOLOGY

Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study

(2009) Barbara Drueke et al.   PSYCHOPHARMACOLOGY

Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study

(2008) A WITTORF et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

Working-memory fMRI reveals cingulate hyperactivation in euthymic major depression

(2008) Sonja Schöning et al.   HUMAN BRAIN MAPPING

Quetiapine augmentation in depressed patients with partial response to antidepressants

(2008) James S Olver et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity

(2008) A.E. Castaneda et al.   JOURNAL OF AFFECTIVE DISORDERS

The Effects of Venlafaxine on Cognitive Functions and Quantitative EEG in Healthy Volunteers

(2008) T. Siepmann et al.   PHARMACOPSYCHIATRY

Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder

(2008) Ixchel Herrera-Guzmán et al.   PSYCHIATRY RESEARCH

Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial

(2008) Shahin Akhondzadeh et al.   SCHIZOPHRENIA RESEARCH

A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory

(2008) M KING et al.   TRENDS IN PHARMACOLOGICAL SCIENCES